We are live on ! Find out more
ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

72 hedge funds and large institutions have $815M invested in Intercept Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

104% more capital invested

Capital invested by funds: $399M → $815M (+$416M)

87% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 15

26% more funds holding

Funds holding: 57 → 72 (+15)

Holders
72
Holders Change
+15
Holders Change %
+26.32%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
22
Increased
28
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCA
SAC Capital Advisors
Connecticut
+$23.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.2M
3
TCIM
TIAA CREF Investment Management
New York
+$7.88M
4
Millennium Management
Millennium Management
New York
+$7.33M
5
EA
Emerald Advisers
Pennsylvania
+$5.94M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$6.42M
2
PC
Polar Capital
United Kingdom
-$6.27M
3
BBA
Baker Bros. Advisors
New York
-$4.94M
4
JP Morgan Chase
JP Morgan Chase
New York
-$4.76M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.63M

ICPT Hedge Fund Activity: Q3 2013 in Review

72 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q3 2013, worth a combined $815M — up 104% from $399M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ICPT positions and 7 closed out — a net gain of 15 holders — while 28 added to existing stakes and 15 trimmed.

The largest buyer was SAC Capital Advisors, adding an estimated $23.5M. The largest seller was Capital World Investors, cutting an estimated $6.42M.

  • 72 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q3 2013, up from 57 in Q2 2013.
  • Funds reported $815M of Intercept Pharmaceuticals, Inc. stock for Q3 2013, up 104% quarter-over-quarter.
  • 22 funds opened new Intercept Pharmaceuticals, Inc. positions in Q3 2013 and 7 closed out, a net change of +15 holders.
  • The largest Intercept Pharmaceuticals, Inc. buyer in Q3 2013 was SAC Capital Advisors, an estimated $23.5M added.
  • The largest Intercept Pharmaceuticals, Inc. seller in Q3 2013 was Capital World Investors, an estimated $6.42M sold.

Based on aggregated 13F filings for Q3 2013.